Standout Papers

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI)... 2010 2026 2015 2020 734
  1. Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer (2010)
    Marc Peeters, Timothy Price et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 14 from Science/Nature 71 standout
Sub-graph 1 of 21

Citing Papers

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial
2023 Standout
Targeting HER2-positive breast cancer: advances and future directions
2022 Standout

Works of G. Wilson being referenced

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
2004
A ‘modified de Gramont’ regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer
2002

Author Peers

Author Last Decade Papers Cites
G. Wilson 1476 733 265 338 34 1.8k
Martin Šmakal 2064 877 370 299 26 2.6k
Cees J. van Groeningen 1265 535 224 231 29 1.7k
Veronica Lonati 1234 643 399 372 42 1.8k
Massimo Lopez 1563 586 506 277 59 2.2k
C. J. Rodenburg 1906 769 364 455 37 2.7k
Mario Barugel 1492 678 231 391 29 1.7k
Philip J. Gold 1406 739 221 436 63 2.2k
John Macintyre 1122 566 231 594 32 1.7k
I. Shchepotin 1625 842 288 370 37 2.4k
Jean-Luc Canon 2269 1040 422 324 31 2.7k

All Works

Loading papers...

Rankless by CCL
2026